Product Images Nexavar

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 6 images provide visual information about the product associated with Nexavar NDC 50419-488 by Bayer Healthcare Pharmaceuticals Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

7c4c29f2 1bbf 4eb3 8685 a44154d1c198 00

7c4c29f2 1bbf 4eb3 8685 a44154d1c198 00

Structural formula - image 01

Structural formula - image 01

fig 1 - image 02

fig 1 - image 02

Fig 2 - image 03

Fig 2 - image 03

This text is describing the progression-free survival probability and median survival time in days for patients who received NEXAVAR (N=384) and Placebo (N=385). It also includes Hazard Ratio and p-value. The text also presents a graph with the survival probability over time.*

Fig 3 - image 04

Fig 3 - image 04

The text shows results of a clinical trial evaluating the efficacy of NEXAVAR compared to a placebo. The study included 207 patients in the NEXAVAR group and 210 patients in the Placebo group. The text provides a graph showing the proportion of progression-free survival over time for each treatment group. It also includes a table showing the number of patients at risk in each group at various time points during the study.*

label

label

This is a product description for Nexavar tablets manufactured by Bayer HealthCare Pharmaceuticals. Each tablet contains 200mg sorafenib and there are 120 tablets in a bottle. The NDC number is 5041948356 and the batch number and expiry date are not available due to incomplete reading.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.